Highlights in Cerebral Small Vessel Disease in 2022

doi:10.3969/j.issn.1673-5765.2023.01.002

Abstract

关键词: 脑龄; 脑小血管病; 认知障碍; 脑小血管病临床试验设计框架; 炎症; 遗传

WANG Yilong, CHEN Weiqi, YE Jinyi, ZHOU Mengyuan, JIANG Lingling, LIU Dong, QIU Baoshan, GAO Ying, ZHAO Yilong, WANG Zan, LI Pengfei . Highlights in Cerebral Small Vessel Disease in 2022[J]. Chinese Journal of Stroke, 2023, 18(01): 17-41.

王伊龙, 陈玮琪, 叶瑾怡, 周梦圆, 江凌玲, 刘东, 邱宝山, 高颖, 赵一龙, 王赞, 李鹏飞. 脑小血管病：回眸2022[J]. 中国卒中杂志, 2023, 18(01): 17-41.

References

[1] CHARIDIMOU A，PANTONI L，LOVE S. The concept of sporadic cerebral small vessel disease：a road map on key definitions and current concepts[J]. Int J Stroke，2016，11（1）：6-18.
[2] SMITH E E，MARKUS H S. New treatment approaches to modify the course of cerebral small vessel diseases[J]. Stroke，2020，51（1）：38-46.
[3] MARKUS H S，FLIER W M，SMITH E E，et al. Framework for clinical trials in cerebral small vessel disease（FINESSE）：a review[J]. JAMA Neurol，2022，79（11）：1187-1198.
[4] CANNISTRARO R J，BADI M，EIDELMAN B H，et al. CNS small vessel disease：a clinical review[J]. Neurology，2019，92（24）：1146-1156.
[5] BERNBAUM M，MENON B K，FICK G，et al. Reduced blood flow in normal white matter predicts development of leukoaraiosis[J]. J Cereb Blood Flow Metab，2015，35（10）：1610-1615.
[6] VEEN P H，MULLER M，VINCKEN K L，et al. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow：the second manifestations of arterial disease-magnetic resonance study[J]. Stroke，2015，46（5）：1233-1238.
[7] TEICH A F，SAKURAI M，PATEL M，et al. PDE5 exists in human neurons and is a viable therapeutic target for neurologic disease[J]. J Alzheimers Dis，2016，52（1）：295-302.
[8] VASITA E，YASMEEN S，ANDOH J，et al. The cGMP-degrading enzyme phosphodiesterase-5（PDE5）in cerebral small arteries of older people[J]. J Neuropathol Exp Neurol，2019，78（2）：191-194.
[9] FORGUE S T，PATTERSON B E，BEDDING A W，et al. Tadalafil pharmacokinetics in healthy subjects[J]. Br J Clin Pharmacol，2006，61（3）：280-288.
[10] GARCIA-OSTA A，CUADRADO-TEJEDOR M，GARCIA-BARROSO C，et al. Phosphodiesterases as therapeutic targets for Alzheimer’s disease[J]. ACS Chem Neurosci，2012，3（11）：832-844.
[11] PAULS M M H，BINNIE L R，BENJAMIN P，et al. The PASTIS trial：testing tadalafil for possible use in vascular cognitive impairment[J]. Alzheimers Dement，2022，18（12）：2393-2402.
[12] PFLANZ C P，EGLE M S，O’BRIEN J T，et al. Association of blood pressure lowering intensity with white matter network integrity in patients with cerebral small vessel disease[J/OL]. Neurology，2022，99（17）：e1945-e1953[2023-01-03]. https://doi.org/10.1212/wnl.0000000000201018.
[13] UMEMOTO S，OGIHARA T，MATSUZAKI M，et al. Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability：post hoc analysis of the COPE trial[J]. Hypertens Res，2016，39（1）：46-53.
[14] GOLDSTEIN E D，WOLCOTT Z，GARG G，et al. Effect of antihypertensives by class on cerebral small vessel disease：a post hoc analysis of SPRINT-MIND[J]. Stroke，2022，53（8）：2435-2440.
[15] SHIN H K，SALOMONE S，AYATA C. Targeting cerebrovascular Rho-kinase in stroke[J]. Expert Opin Ther Targets，2008，12（12）：1547-1564.
[16] MATSUI T，AMANO M，YAMAMOTO T，et al. Rho-associated kinase，a novel serine/threonine kinase，as a putative target for small GTP binding protein Rho[J]. Embo J，1996，15（9）：2208-2216.
[17] AYKAN S A，XIE H Y，ZHENG Y，et al. Rho-kinase inhibition improves the outcome of focal subcortical white matter lesions[J]. Stroke，2022，53（7）：2369-2376.
[18] BENAVENTE O R，HART R G，MCCLURE L A，et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke[J]. N Engl J Med，2012，367（9）：817-825.
[19] KWOK C S，SHOAMANESH A，COPLEY H C，et al. Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke：pooled analysis of randomized trials[J]. Stroke，2015，46（4）：1014-1023.
[20] SHINOHARA Y，KATAYAMA Y，UCHIYAMA S，et al. Cilostazol for prevention of secondary stroke（CSPS 2）：an aspirin-controlled，double-blind，randomised non-inferiority trial[J]. Lancet Neurol，2010，9（10）：959-968.
[21] OYAMA N，YAGITA Y，KAWAMURA M，et al. Cilostazol，not aspirin，reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats[J]. Stroke，2011，42（9）：2571-2577.
[22] KIM B C，YOUN Y C，JEONG J H，et al. Cilostazol versus aspirin on white matter changes in cerebral small vessel disease：a randomized controlled trial[J]. Stroke，2022，53（3）：698-709.
[23] BLAIR G W，JANSSEN E，STRINGER M S，et al. Effects of cilostazol and isosorbide mononitrate on cerebral hemodynamics in the LACI-1 randomized controlled trial[J]. Stroke，2022，53（1）：29-33.
[24] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories，1990-2019：a systematic analysis for the global burden of disease study 2019[J]. Lancet，2020，396（10258）：1204-1222.
[25] WASSENAAR T M，YAFFE K，VAN DER WERF Y D，et al. Associations between modifiable risk factors and white matter of the aging brain：insights from diffusion tensor imaging studies[J/OL]. Neurobiol Aging，2019，80：56-70[2023-01-03]. https://doi.org/10.1016/j.neurobiolaging.2019.04.006.
[26] BERRY C，SIDIK N，PEREIRA A C，et al. Small-vessel disease in the heart and brain：current knowledge，unmet therapeutic need，and future directions[J/OL]. J Am Heart Assoc，2019，8（3）：e011104[2023-01-03]. https://doi.org/10.1161/jaha.118.011104.
[27] MEJIA-RENTERIA H，TRAVIESO A，MATÍAS-GUIU J A，et al. Coronary microvascular dysfunction is associated with impaired cognitive function：the cerebral-coronary connection study（C3 study）[J]. Eur Heart J，2023，44（2）：113-125.
[28] FERGUSON A C，THRIPPLETON S，HENSHALL D，et al. Frequency and phenotype associations of rare variants in 5 monogenic cerebral small vessel disease genes in 200，000 UK biobank participants[J/OL]. Neurol Genet，2022，8（5）：e200015[2023-01-03]. https://doi.org/10.1212/nxg.0000000000200015.
[29] MISHRA A，DUPLAÀ C，VOJINOVIC D，et al. Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate[J]. Brain，2022，145（6）：1992-2007.
[30] HARSHFIELD E L，SANDS C J，TULADHAR A M，et al. Metabolomic profiling in small vessel disease identifies multiple associations with disease severity[J]. Brain，2022，145（7）：2461-2471.
[31] PEROSA V，OLTMER J，MUNTING L P，et al. Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex[J]. Acta Neuropathol，2022，143（3）：331-348.
[32] VELUW S J，BIESSELS G J，BOUVY W H，et al. Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces[J]. J Cereb Blood Flow Metab，2016，36（3）：576-580.
[33] MONTAGNE A，ZHAO Z，ZLOKOVIC B V. Alzheimer’s disease：a matter of blood-brain barrier dysfunction? [J]. J Exp Med，2017，214（11）：3151-3169.
[34] CUADRADO-GODIA E，DWIVEDI P，SHARMA S，et al. Cerebral small vessel disease：a review focusing on pathophysiology，biomarkers，and machine learning strategies[J]. J Stroke，2018，20（3）：302-320.
[35] KALARIA R N. Small vessel disease and Alzheimer’s dementia：pathological considerations[J/OL]. Cerebrovasc Dis，2002，13（Suppl 2）：48-52[2023-01-03]. https://doi.org/10.1159/000049150.
[36] CHENG X，HE P，YAO H L，et al. Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy[J]. Neurology，2014，82（19）：1707-1715.
[37] ROSSNER S，LANGE-DOHNA C，ZEITSCHEL U，et al. Alzheimer’s disease beta-secretase BACE1 is not a neuron-specific enzyme[J]. J Neurochem，2005，92（2）：226-234.
[38] BOURASSA P，TREMBLAY C，SCHNEIDER J A，et al. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex：relation with cerebral amyloid angiopathy and Alzheimer’s disease[J]. Acta Neuropathol，2019，137（5）：801-823.
[39] ZHOU H Y，GAO F，YANG X L，et al. Endothelial BACE1 impairs cerebral small vessels via tight junctions and eNOS[J]. Circ Res，2022，130（9）：1321-1341.
[40] CAI M F，JACOB M A，VAN LOENEN M R，et al. Determinants and temporal dynamics of cerebral small vessel disease：14-year follow-up[J]. Stroke，2022，53（9）：2789-2798.
[41] VERBURGT E，JANSSEN E，JACOB M A，et al. Role of small acute hyperintense lesions in long-term progression of cerebral small vessel disease and clinical outcome：a 14-year follow-up study[J]. J Neurol Neurosurg Psychiatry，2023，94（2）：144.
[42] KUO C Y，TAI T M，LEE P L，et al. Improving individual brain age prediction using an ensemble deep learning framework[J/OL]. Frontiers in psychiatry，2021，12：626677[2023-01-03]. https://doi.org/10.3389/fpsyt.2021.626677.
[43] WARDLAW J M，SMITH C，DICHGANS M. Small vessel disease：mechanisms and clinical implications[J]. Lancet Neurol，2019，18（7）：684-696.
[44] LEE P L，KUO C Y，WANG P N，et al. Regional rather than global brain age mediates cognitive function in cerebral small vessel disease[J/OL]. Brain Commun，2022，4（5）：fcac233[2023-01-03]. https://doi.org/10.1093/braincomms/fcac233.
[45] HABES M，POMPONIO R，SHOU H C，et al. The brain chart of aging：machine-learning analytics reveals links between brain aging，white matter disease，amyloid burden，and cognition in the iSTAGING consortium of 10，216 harmonized MR scane[J]. Alzheimers Dement，2021，17（1）：89-102.
[46] KATZMAN R，TERRY R，DETERESA R，et al. Clinical，pathological，and neurochemical changes in dementia：a subgroup with preserved mental status and numerous neocortical plaques[J]. Ann Neurol，1988，23（2）：138-144.
[47] SNOWDON D A，KEMPER S J，MORTIMER J A，et al. Linguistic ability in early life and cognitive function and Alzheimer’s disease in late life. Findings from the Nun study[J]. JAMA，1996，275（7）：528-532.
[48] DEJONG N R，JANSEN J F A，VAN BOXTEL M P J，et al. Cognitive resilience depends on white matter connectivity：the Maastricht study[J/OL]. Alzheimers Dement，2022：12758[2023-01-03]. https://doi.org/10.1002/alz.12758.
[49] NG F C，CHURILOV L，YASSI N，et al. Prevalence and significance of impaired microvascular tissue reperfusion despite macrovascular angiographic reperfusion（No-Reflow）[J/OL]. Neurology，2022，98（8）：e790-e801[2023-01-03]. https://doi.org/10.1212/wnl.0000000000013210.
[50] QIU B S，ZHAO Z C，WANG N，et al. A systematic observation of vasodynamics from different segments along the cerebral vasculature in the penumbra zone of awake mice following cerebral ischemia and recanalization[J/OL]. J Cereb Blood Flow Metab，2022：271678x221146128. https://doi.org/10.1177/0271678x221146128.